Cargando…
Health care cost associated with the use of enzyme-inducing and non-enzyme–active antiepileptic drugs in the UK: a long-term retrospective matched cohort study
BACKGROUND: Some antiepileptic drugs (AEDs) induce expression of hepatic enzymes. This can contribute to comorbidities via interference with metabolic pathways and concomitant drug metabolization, thereby increasing the likelihood of health care interventions. Using medical records, we compared the...
Autores principales: | Borghs, Simon, Thieffry, Solène, Noack-Rink, Matthias, Dedeken, Peter, Hong, Lai San, Byram, Laura, Logan, John, Chan, Jane, Kiri, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364597/ https://www.ncbi.nlm.nih.gov/pubmed/28335764 http://dx.doi.org/10.1186/s12883-017-0837-y |
Ejemplares similares
-
Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study
por: Borghs, Simon, et al.
Publicado: (2020) -
Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records
por: Powell, Graham, et al.
Publicado: (2019) -
Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta‐analyses and real‐world evidence on antiepileptic drugs
por: Thieffry, Solène, et al.
Publicado: (2020) -
Lacosamide and sodium channel‐blocking antiepileptic drug cross‐titration against levetiracetam background therapy
por: Baulac, M., et al.
Publicado: (2016) -
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
por: Saruwatari, Junji, et al.
Publicado: (2010)